Literature DB >> 22727416

Embolization to treat pelvic congestion syndrome and vulval varicose veins.

Carine J M van der Vleuten1, Janneke A L van Kempen, Leo J Schultze-Kool.   

Abstract

OBJECTIVE: To evaluate the efficacy of embolization for treating the symptoms of pelvic congestion syndrome (PCS).
METHODS: Twenty-one women with PCS who were treated with embolization at Radboud University Nijmegen Medical Centre between 2003 and 2008 were sent a questionnaire about their symptoms before embolization, 2 months after the first embolization, and at the time the survey was conducted.
RESULTS: All patients completed the questionnaire. Two months after the first embolization, 14 (66.7%) women had some degree of improvement of symptoms. Nine (42.9%) patients underwent a second embolization. At the time the survey was conducted, 16 (76.2%) patients had some degree of improvement of symptoms. In addition to improvements in varicose veins and pelvic pain, there was improvement of hemorrhoids.
CONCLUSION: Embolization of pelvic varicosities may be an effective treatment in a well-selected group of patients with PCS. If there is no improvement of symptoms after initial embolization, a second procedure is unlikely to be effective.
Copyright © 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727416     DOI: 10.1016/j.ijgo.2012.04.021

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

Review 1.  Pelvic vein incompetence: clinical perspectives.

Authors:  David M Riding; Vivak Hansrani; Charles McCollum
Journal:  Vasc Health Risk Manag       Date:  2017-11-27

Review 2.  Pelvic congestion syndrome and embolization of pelvic varicose veins.

Authors:  Mateus Picada Corrêa; Larissa Bianchini; Jaber Nashat Saleh; Rafael Stevan Noel; Julio Cesar Bajerski
Journal:  J Vasc Bras       Date:  2019-11-08

3.  Ovarian Vein Embolization With N-butyl-2 Cyanoacrylate Glubran-2® for the Treatment of Pelvic Venous Disorder.

Authors:  Maofeng Gong; Xu He; Boxiang Zhao; Jie Kong; Jianping Gu; Haobo Su
Journal:  Front Surg       Date:  2021-12-16

Review 4.  Comprehensive overview of the venous disorder known as pelvic congestion syndrome.

Authors:  Kamil Bałabuszek; Michał Toborek; Radosław Pietura
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.